The U.S. Food and Drug Administration recalled more than 140,000 bottles of a common statin medication. Is your medication ...

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 ...

The Food and Drug Administration recalled hundreds of thousands of bottles of the cholesterol drug Atorvastatin Calcium ...

The recall comes after the maker determined the drug may not dissolve or release its active ingredient in a way that meets ...

Ascend Laboratories, LLC, a New Jersey-based pharmaceutical company, has recalled over 141,000 bottles of cholesterol medication. An advisory from the company suggests that the drugs may have failed ...

New Jersey-based Ascend Laboratories has voluntarily recalled 141,984 bottles of atorvastatin calcium, a cholesterol-lowering ...

Your prescription may be involved. The FDA explains why suddenly stopping your medication is more harmful than taking it.

The study focuses on mycophenolate, a medication used primarily in organ transplantation and autoimmune diseases, to monitor pregnancy outcomes and potential birth defects. This is part of a Risk ...

For the latest installment in what’s become somewhat of a routine, European drug regulators are cracking down on data manipulation originating in India’s biopharma industry. This time, it’s Mumbai’s ...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when ...

Based on the one-year price targets offered by 17 analysts, the average target price for Alkem Laboratories Ltd (NSE:ALKEM) is $5726.05 with a high estimate of $7225.00 and a low estimate of $4330.00.